These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38986982)

  • 1. Protective effects of DcR3-SUMO on lipopolysaccharide-induced inflammatory cells and septic mice.
    Su J; Tong Z; Feng Z; Wu S; Zhou F; Li R; Chen W; Ye Z; Guo Y; Yao S; Yu X; Chen Q; Chen L
    Int J Biol Macromol; 2024 Aug; 275(Pt 2):133703. PubMed ID: 38986982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory mechanisms of decoy receptor 3 in cecal ligation and puncture-induced sepsis.
    Su J; Chen W; Zhou F; Li R; Tong Z; Wu S; Ye Z; Zhang Y; Lin B; Yu X; Guan B; Feng Z; Chen K; Chen Q; Chen L
    mBio; 2024 Jun; 15(6):e0052124. PubMed ID: 38700314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoy Receptor 3 Improves Survival in Experimental Sepsis by Suppressing the Inflammatory Response and Lymphocyte Apoptosis.
    Liang D; Hou Y; Lou X; Chen H
    PLoS One; 2015; 10(6):e0131680. PubMed ID: 26121476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DcR3-TL1A signalling inhibits cytokine-induced proliferation of rheumatoid synovial fibroblasts.
    Takahashi M; Miura Y; Hayashi S; Tateishi K; Fukuda K; Kurosaka M
    Int J Mol Med; 2011 Sep; 28(3):423-7. PubMed ID: 21537832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions.
    Hsieh SL; Lin WW
    J Biomed Sci; 2017 Jun; 24(1):39. PubMed ID: 28629361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and synovial fluid levels of tumor necrosis factor-like ligand 1A and decoy receptor 3 in rheumatoid arthritis.
    Xiu Z; Shen H; Tian Y; Xia L; Lu J
    Cytokine; 2015 Apr; 72(2):185-9. PubMed ID: 25647275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal Structure of the Complex of Human FasL and Its Decoy Receptor DcR3.
    Liu W; Ramagopal U; Cheng H; Bonanno JB; Toro R; Bhosle R; Zhan C; Almo SC
    Structure; 2016 Nov; 24(11):2016-2023. PubMed ID: 27806260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High intestinal and systemic levels of decoy receptor 3 (DcR3) and its ligand TL1A in active ulcerative colitis.
    Bamias G; Kaltsa G; Siakavellas SI; Papaxoinis K; Zampeli E; Michopoulos S; Zouboulis-Vafiadis I; Ladas SD
    Clin Immunol; 2010 Nov; 137(2):242-9. PubMed ID: 20675196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions.
    Bamias G; Evangelou K; Vergou T; Tsimaratou K; Kaltsa G; Antoniou C; Kotsinas A; Kim S; Gorgoulis V; Stratigos AJ; Sfikakis PP
    Exp Dermatol; 2011 Sep; 20(9):725-31. PubMed ID: 21672030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decoy strategies: the structure of TL1A:DcR3 complex.
    Zhan C; Patskovsky Y; Yan Q; Li Z; Ramagopal U; Cheng H; Brenowitz M; Hui X; Nathenson SG; Almo SC
    Structure; 2011 Feb; 19(2):162-71. PubMed ID: 21300286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer.
    Lin WW; Hsieh SL
    Biochem Pharmacol; 2011 Apr; 81(7):838-47. PubMed ID: 21295012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decoy receptor 3 regulates the expression of various genes in rheumatoid arthritis synovial fibroblasts.
    Fukuda K; Miura Y; Maeda T; Takahashi M; Hayashi S; Kurosaka M
    Int J Mol Med; 2013 Oct; 32(4):910-6. PubMed ID: 23912906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decoy Receptor 3 Suppresses T-Cell Priming and Promotes Apoptosis of Effector T-Cells in Acute Cell-Mediated Rejection: The Role of Reverse Signaling.
    Weng SC; Wen MC; Hsieh SL; Chen NJ; Tarng DC
    Front Immunol; 2022; 13():879648. PubMed ID: 35720343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DcR3 promotes hepatoma cell migration by downregulating E-cadherin expression.
    Zhang H; Chen X; Li D; Cui L; Li X; Ye X; Wan X
    Oncol Rep; 2017 Jul; 38(1):377-383. PubMed ID: 28560426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNFSF/TNFRSF cytokine gene expression in sickle cell anemia: Up-regulated TNF-like cytokine 1A (TL1A) and its decoy receptor (DcR3) in peripheral blood mononuclear cells and plasma.
    Safaya S; Alfarhan M; Sulaiman A; Alsulaiman A; Al-Ali A
    Cytokine; 2019 Nov; 123():154744. PubMed ID: 31255916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TL1A/DR3/DcR3 pathway in autoimmune rheumatic diseases.
    Siakavellas SI; Sfikakis PP; Bamias G
    Semin Arthritis Rheum; 2015 Aug; 45(1):1-8. PubMed ID: 25887448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DcR3 suppresses influenza virus-induced macrophage activation and attenuates pulmonary inflammation and lethality.
    Huang MT; Chen ST; Wu HY; Chen YJ; Chou TY; Hsieh SL
    J Mol Med (Berl); 2015 Oct; 93(10):1131-43. PubMed ID: 25940317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DcR3 protects islet beta cells from apoptosis through modulating Adcyap1 and Bank1 expression.
    Han B; Wu J
    J Immunol; 2009 Dec; 183(12):8157-66. PubMed ID: 20007581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin‑12B is upregulated by decoy receptor 3 in rheumatoid synovial fibroblasts.
    Fukuda K; Miura Y; Maeda T; Hayashi S; Kurosaka M
    Mol Med Rep; 2016 Apr; 13(4):3647-52. PubMed ID: 26956410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation.
    Siakavellas SI; Bamias G
    Inflamm Bowel Dis; 2015 Oct; 21(10):2441-52. PubMed ID: 26099067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.